// App-Quantinova.ai

e22023 : ClearCell FX: A microfluidic system for label-free circulating tumor cell enrichment.

Researchers

Presenter

  • Andrew Wu

Principal Investigators

  • Ali Asgar Bhagat

  • Man Chun Leong

  • Chwee Teck Lim

Medical Centers

  • Clearbridge Biomedics Pte Ltd, Singapore, Singapore

  • National University of Singapore, Singapore, SingaporeClearbridge BioMedics, Singapore, Singapore

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved